U.S. Coronavirus Deaths: 15 Medical Experts Predict What 2021 Will Bring
To date, the United States has witnessed more than 356,000 deaths over the past eleven months of the pandemic by far the highest total for any country worldwide. Here is what 15 medical experts told us what could come next.
With nearly 78,000 deaths, December was the deadliest month of the ongoing coronavirus pandemic in the United States.
How will January fare? It appears that more misery is in the offing as the nation’s top health officials have warned that even more people will likely die this month despite vaccine campaigns ramping up in many states.
FDA approves anti-obesity medicine for teens
and last updated 2020-12-30 21:58:42-05
For the first time in 17 years, the FDA has approved an anti-obesity medicine for teens. As of now, one in five teens in the U.S. have the disease, and the pandemic is not helping. As the drug heads to the open market, researchers are working to get it to those who need it most.
âObesity is primarily a biologically driven disease,â said Dr. Aaron Kelly, co-chair of the
The center focuses on intervention and treatment. Kelly says, like diabetes or high blood pressure, it has to be treated and managed.
CBS reports The Fauci effect is leading to increased med school applications bizpacreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bizpacreview.com Daily Mail and Mail on Sunday newspapers.
Published: Dec 18, 2020
Westport, CT, Dec. 18, 2020 (GLOBE NEWSWIRE) BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced that the Company and its NeuroClear Technologies division signed a new research agreement with the University of Minnesota.
Under the terms of the agreement, the Company intends to launch a program to develop novel therapies to treat sympathetic nervous system disease. Due to launch in Q4 2020, the program studies are expected to form a foundation for developing a new platform technology to address disorders of the autonomic nervous system. NeuroClear intends to develop new intellectual properties and products, including new hardware, software, and algorithmic solutions, with the support of a tier 1 US-based manufacturing
Health officials are watching coronavirus mutations overseas, but they still expect the vaccine to be highly effective. Author: Danny Spewak Updated: 10:17 PM CST December 22, 2020
The world has paid close attention in recent days to mutations of the novel coronavirus, discovered most prominently in the United Kingdom and South Africa.
The revelation led to heightened restrictions in London and southeastern England this week, with UK Home Secretary Priti Patel telling the public in a televised interview that “we have to take strong measures, and we’re doing that.” Some countries have closed their borders in response, while several airlines in the United States – at the suggestion of Gov. Andrew Cuomo – will now require negative tests for U.K. travelers entering New York City via JFK Airport.